121. Improving Predictive Value of Phase 2a TB Drug Development Models Through PET/CT Imaging (NexGen EBA)

BACKGROUND: Current Phase 2a methods in tuberculosis (TB) drug development are severely limited in capturing a drug candidate’s sterilizing activity (ability to prevent TB relapse). We hypothesize that sputum-based measurements of current methods fail to capture drug activity in deep TB lesion compa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Xie, Yingda, Via, Laura, Chen, Ray, Dodd, Lori, Cai, Ying, Paripati, Paveen, Goldfeder, Lisa, Winter, Jill, Arora, Kriti, Wang, Jing, De Jagar, Veronique, Malherbe, Stephanus, Song, Taeksun, Walzl, Gerhard, Diacon, Andreas, III, Clifton Barry
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6252863/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy209.012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados